CGEM compared with AMGN: revenue, margins and what each company keeps, and the suppliers and customers both name

CGEMCullinan Therapeutics, Inc.

Mkt capRevenueRevenue

AMGNAmgen Inc

Mkt capRevenueRevenue

Compare

CGEMCullinan Therapeutics, Inc.

AMGNAmgen Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

CGEMCullinan Therapeutics, Inc.

12.48▼−20.76%· post 12.25

Mkt cap$803.8MRevenue—Revenue—

AMGNAmgen Inc

478.34▲+3.70%· post 480.00

ClosedNov 4 '26

Mkt cap$258.8BRevenue$10.4BQ3 FY26Revenue$36.8BFY25

Compare

ClosedNov 4 '26

CGEMCullinan Therapeutics, Inc.

AMGNAmgen Inc

12.48▼−20.76%post 12.25

Price

478.34▲+3.70%post 480.00

$803.8M

Mkt cap

$258.8B

—

Revenue

$10.4BQ3 FY26

—

Revenue

$36.8BFY25

CGEM12.48▼−20.76%vsAMGN478.34▲+3.70%ClosedNov 4 '26

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

CGEM: latest quarter not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only CGEM 7

—Chongqing Genrix Biopharmaceuticalunlistedsupplier

—Harbour BioMed USunlistedsupplier

—Taiho Pharmaceuticalunlistedsupplier

—Deutsches Krebsforschungszentrumunlistedsupplier

3 more · CGEM chain ›

Shared 0

No shared counterparties.

Only AMGN 12

PODDInsuletsupplier

CYTKCytokineticssupplier

ARWRArrowhead Pharmaceuticalssupplier

LGNDLigand Pharmaceuticalssupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

8 more · AMGN chain ›

Price

rebased to 0%

CGEM, solidAMGN, dashed